Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиDaré Bioscience Мультипликаторы 2011-2024 | DARE
Мультипликаторы по годам Daré Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.4 | -2.8 | -3.2 | -0.0 | -1.2 | -0.5 | -0.6 | -0.6 | -1.5 | -4.8 | - | - | - |
P/S |
15.2 | 8.5 | - | - | - | - | - | 28.6 | - | 1411.2 | - | - | - |
EPS |
-0.3 | -0.4 | -0.6 | -0.9 | -1.0 | 1.6 | 3.6 | -1.4 | -1.6 | -1.6 | -25.1 | -36.4 | - |
EV (Enterprise Value) |
58.6 млн | 83.5 млн | 87.7 млн | 75.4 млн | 19.8 млн | 2.86 млн | 357 тыс. | 46.4 млн | 14.6 млн | 69.8 млн | 4.13 млн | 81 млн | - |
EBITDA per Share |
-0.35 | -0.37 | -0.64 | -867 | -0.92 | -1.09 | -1.14 | -13.3 | -14.5 | -13.9 | - | - | - |
EV/EBITDA |
-2.2 | -0.0 | -0.9 | -0.2 | 0.2 | 0.0 | -0.1 | -3.2 | - | - | - | ||
PEG |
-0.0 | -0.0 | -0.0 | 0.0 | -0.03 | -0.01 | -0.01 | -0.06 | -0.62 | -0.21 | - | - | - |
P/B |
-8.5 | 7.7 | 3.2 | -62.0 | 39.9 | 1.3 | 0.5 | 1.7 | 1.3 | 2.5 | - | - | - |
P/CF |
-1.1 | -4.7 | -4.3 | -2.8 | -1.3 | -0.8 | -2.7 | -0.6 | -1.9 | -5.9 | - | - | - |
ROE % |
597.53 | -278.50 | -99.85 | 2379088.12 | -3235.71 | -248.84 | -86.54 | -299.79 | -81.23 | -51.50 | - | - | - |
ROA % |
-141.72 | -70.61 | -69.34 | -362889.53 | -191.65 | -213.85 | -80.67 | -104.29 | -50.62 | -43.72 | - | - | - |
ROCE % |
612.96 | -282.44 | -100.81 | 24936305.73 | -783.71 | -173.61 | -27.76 | -179.06 | -60.06 | -44.73 | - | - | - |
Current Ratio |
0.8 | 1.3 | 3.3 | 0.9 | 1.1 | 6.6 | 8.6 | 2.2 | 4.7 | 6.6 | - | - | - |
DSO |
- | - | - | - | - | - | - | 876.8 | - | 7582.9 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Daré Bioscience
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.09 | -0.1 | -0.09 | - | -0.08 | - | -0.1 | - | -0.18 | -0.18 | -0.16 | - | -0.24 | -0.27 | -0.18 | - | -0.2 | -0.29 | -0.27 | - | -0.23 | -0.32 | -0.88 | - | -0.33 | -0.55 | -0.27 | -0.17 | -0.02 | -3.97 | -0.49 | -0.39 | -0.39 | -0.37 | -0.41 | -0.37 | -0.28 | -0.44 | -3.7 | -4.45 | -4.4 | -7.96 | -9.09 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.1 | - | -0.08 | - | -0.1 | - | -0.18 | -0.18 | -0.17 | - | -0.24 | -0.27 | -0.18 | - | -0.2 | -0.25 | -0.27 | - | -0.23 | -0.32 | -0.88 | - | -0.27 | -0.53 | -0.18 | - | -0.01 | -0.09 | - | - | - | - | - | - | - | - | 0.05 | - | 0.22 | 0.2 | 0.12 | - | - | - | - | - | - | - | - |
ROE % |
496.40 | 107.15 | -213.81 | -52.59 | -92.32 | -105.39 | -224.97 | -382.82 | 275.56 | 973.67 | 1710.56 | 1646.15 | 876.44 | -551.65 | -2066.81 | -2358.61 | -2396.88 | -1665.45 | -822.10 | -205.49 | -217.75 | -191.73 | -142.23 | -17.84 | 678.03 | 692.55 | 613.48 | 512.03 | 22641.90 | 22617.98 | 22680.48 | 22766.49 | -75.72 | -66.34 | -62.34 | -51.50 | -31.33 | -15.68 | 5.84 | 18.18 | 14.49 | 11.10 | 5.91 | - | - | - | - | - | - | - | - |
ROA % |
-111.30 | -92.11 | -53.55 | -30.20 | -56.16 | -68.17 | -130.80 | -157.40 | -257.82 | -332.29 | -364.83 | -251.09 | -296.68 | -241.85 | -200.60 | -139.70 | -172.59 | -159.89 | -152.55 | -176.59 | -188.02 | -166.55 | -124.28 | -16.63 | -11100.60 | -11125.27 | -11150.59 | -11184.81 | -2383.69 | -2361.08 | -2344.94 | -2319.77 | -50.90 | -47.82 | -49.02 | -43.72 | -80.71 | -117.14 | -174.95 | -251.11 | -200.13 | -153.29 | -81.62 | - | - | - | - | - | - | - | - |
ROCE % |
-27.10 | -54.20 | -53.03 | -53.14 | -92.87 | -105.50 | -224.98 | -394.18 | 264.12 | 962.14 | 1699.17 | 1646.36 | 870.88 | -562.91 | -2085.02 | -2378.28 | -2417.25 | -1680.74 | -831.22 | -206.99 | -217.03 | -188.08 | -137.61 | -14.99 | -15.08 | -5.13 | -3.33 | -1.71 | -1.71 | -1.62 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.9 | 0.9 | 1.2 | 1.3 | 2.1 | 2.8 | 2.7 | 3.3 | 2.9 | 2.1 | 1.4 | 0.9 | 0.9 | 0.9 | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | 7.1 | 7.1 | 7.1 | 7.1 | 14.8 | 14.8 | 14.8 | 14.8 | 0.1 | 0.1 | - | - | 0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.0 | 75.1 | 49.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.0 | 75.1 | 49.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 81.0 | 75.1 | 49.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD